CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD Micro Invitational on Wednesday, June 5th at 11:40 a.m....
CURE Pharmaceutical
CUREfilm™ is a versatile formulation platform to create proprietary drug products with optimal release profiles for better patient outcomes and experiences. Our formulations can be used in multiple final dosage forms based on the desired drug release profile and user experience.
Biotechnology
1d
5d
1m
6m
1y
Max
CURE Pharmaceutical News
22 May
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397, which covers the high load of bioactive cannabinoid molecules...
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the addition of four key hires to their growing leadership team. Michael Redard will serve as CURE’s Chief...
14 May
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has closed on the previously announced acquisition of Chemistry Holdings Inc. (“Chemistry...
02 May
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the
Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (CURR) to exclusively market and distribute Spee-D®, a weekly dose oral thin film Vitamin...
01 May
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the previously announced acquisition of Chemistry Holdings Inc....
CURE CEO to discuss expanded product pipeline and company’s continued execution into cannabinoid market. LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (CURR), an innovative drug...
26 Apr
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, has been named 2019’s Innovative Business of the Year by Oxnard Chamber of Commerce in recognition to the company’s...
16 Apr
Uptick Newswire Hosts CURE Pharmaceutical on The Stock Day Podcast to Discuss Major Milestones and 2019 Goa
PHOENIX, AZ / ACCESSWIRE / April 16, 2019 / Uptick Newswire Stock Day Podcast welcomed CURE Pharmaceutical (CURR) (''the Company''), a vertically integrated drug delivery and development company committed...
09 Apr
United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced a global healthcare awareness initiative with United Smart Cities for the purpose of educating, informing...
About CURE Pharmaceutical
CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm™), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. Our mission is to improve people's lives by redefining how medicines are delivered and experienced.
Participation in events
- 3rd Benzinga Cannabis Capital Conference
- Toronto, ON M5G 1P5, Canada
$ 0.12
-8.00%
Open:
0.08
High:
0.12
Low:
0.08
Symbol:
CURR
Contact info
Phone:
+1-805-824-0410
+1-805-487-7163
Address:
1620 Beacon Pl, Oxnard, CA 93033, USA
